What to read around the web today

• A recently approved Gilead HIV prevention pill is not cost-effective and price should be cut in half, study says. STAT Plus
• FDA and FTC crack down on coronavirus ‘fraudulent prevention and treatment claims.’ Washington Post
• Publishers roll out alternative routes to open access. Science
• Haunted by a gene. New York Times
• Want to do better science? Admit you’re not objective. Nature